Valencia Technologies

Valencia Technologies, founded with a mission to revolutionize chronic condition treatments, focuses on developing and manufacturing electroceuticals. Their flagship product, eCoin, is a coin-sized, wire-free neurostimulator designed initially for hypertension treatment. The company aims to transform the standard of care for various chronic conditions by leveraging advanced neuromodulation technology. Valencia's market focus includes patients suffering from hypertension and bladder dysfunction, specifically targeting Urge Urinary Incontinence (UUI).

Notable figures associated with Valencia Technologies include key leaders in neuromodulation and medical device innovation. The company has garnered significant attention and investment from the medical and tech communities. Key achievements include the successful development and deployment of eCoin, which has shown promise in clinical trials for both hypertension and bladder control. Valencia Technologies' impact lies in its potential to offer minimally invasive, long-term solutions for chronic conditions, improving patient outcomes and quality of life.